Skip Navigation

Nephrology Dialysis Transplantation 2006 21(Supplement 2):ii63-ii66; doi:10.1093/ndt/gfl193
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cnossen, N.
Right arrow Articles by Leunissen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cnossen, N.
Right arrow Articles by Leunissen, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Peritoneal dialysis in patients with congestive heart failure

Nynke Cnossen1, Jeroen P. Kooman2, Constantijn J. Konings1, Jan-Melle van Dantzig3, Frank M. van der Sande2 and Karel Leunissen2

1 Department of Nephrology, Catharina Ziekenhuis, Eindhoven, The Netherlands, 2 Department of Nephrology, Academisch Ziekenhuis Maastricht, The Netherlands and 3 Department of cardiology, Catharina Hospital, Eindhoven, The Netherlands

Correspondence and offprint requests to: J. P. Kooman, MD, PhD, Department of Nephrology, Academic Hospital Maastricht, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands. Email: jkoo{at}sint.azm.nl

Background. Peritoneal dialysis (PD) may be a useful technique in the treatment of patients with congestive heart failure, both with and without primary end-stage renal disease (ESRD).

Methods. In the treatment of patients with ESRD and congestive heart failure (CHF), PD has theoretical advantages compared with haemodialysis (HD), such as the absence of an arteriovenous fistula and the more gradual fluid removal. In cohort studies, the incidence of heart failure was less as compared with HD, however, randomized studies on this aspect are lacking.

Results. As an acute rescue treatment of patients with treatment refractory heart failure, functional improvement has been observed with the use of PD. However, fluid removal is less predictable compared with continuous haemofiltration therapies.

Conclusions. As a long-term option for patients with treatment refractory CHF without ESRD, various case series showed improved functional performance and a reduction in hospitalization with the use of PD. However, also with the use of PD, median survival is still limited in these patients. Randomized studies are needed to establish the potential role of PD for this indication.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
A. Woywodt, G. Schneider, H. Haller, and M. Hiss
A hopeless case?
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1253 - 1256.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.